Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mong-Hong Lee

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Cancer Communications (London, England)|August 6, 2021
Harness the functions of gut microbiome in tumorigenesis for cancer treatmentMong-Hong Lee
Seminars in Cancer Biology|May 16, 2006
Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteinsMong-Hong Lee, Guillermina Lozano
Cancer Metastasis Reviews|July 30, 2003
Regulators of G1 cyclin-dependent kinases and cancersMong-Hong Lee, Heng-Yin Yang
Gastroenterology Report|February 27, 2018
Dysbiosis of gut microbiota in promoting the development of colorectal cancerShaomin Zou, Lekun Fang, Mong-Hong Lee
Molecular Cancer Therapeutics|March 1, 2006
14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinomaHuiling Yang, Ruiying Zhao, Mong-Hong Lee
Mini Reviews in Medicinal Chemistry|December 17, 2008
Aurora-B kinase inhibitors for cancer chemotherapySai-Ching Jim Yeung, Christopher Gully, Mong-Hong Lee
Oncogene|February 3, 2005
Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicityHuiling Yang, Ruiying Zhao, Heng-Yin Yang, et al.
Journal of Cellular Biochemistry|December 21, 2005
Modified p27 Kip1 is efficient in suppressing HER2-mediated tumorigenicityHeng-Yin Yang, Huiling Yang, Ruiying Zhao, et al.
Cancer Biology & Medicine|April 17, 2014
Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapiesLiem Minh Phan, Sai-Ching Jim Yeung, Mong-Hong Lee
Cell Cycle (Georgetown, Tex.)|August 31, 2011
Roles of COP9 signalosome in cancerMong-Hong Lee, Ruiying Zhao, Liem Phan, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Cancer Communications (London, England)|August 6, 2021
Harness the functions of gut microbiome in tumorigenesis for cancer treatmentMong-Hong Lee
Seminars in Cancer Biology|May 16, 2006
Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteinsMong-Hong Lee, Guillermina Lozano
Cancer Metastasis Reviews|July 30, 2003
Regulators of G1 cyclin-dependent kinases and cancersMong-Hong Lee, Heng-Yin Yang
Gastroenterology Report|February 27, 2018
Dysbiosis of gut microbiota in promoting the development of colorectal cancerShaomin Zou, Lekun Fang, Mong-Hong Lee
Molecular Cancer Therapeutics|March 1, 2006
14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinomaHuiling Yang, Ruiying Zhao, Mong-Hong Lee
Mini Reviews in Medicinal Chemistry|December 17, 2008
Aurora-B kinase inhibitors for cancer chemotherapySai-Ching Jim Yeung, Christopher Gully, Mong-Hong Lee
Oncogene|February 3, 2005
Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicityHuiling Yang, Ruiying Zhao, Heng-Yin Yang, et al.
Journal of Cellular Biochemistry|December 21, 2005
Modified p27 Kip1 is efficient in suppressing HER2-mediated tumorigenicityHeng-Yin Yang, Huiling Yang, Ruiying Zhao, et al.
Cancer Biology & Medicine|April 17, 2014
Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapiesLiem Minh Phan, Sai-Ching Jim Yeung, Mong-Hong Lee
Cell Cycle (Georgetown, Tex.)|August 31, 2011
Roles of COP9 signalosome in cancerMong-Hong Lee, Ruiying Zhao, Liem Phan, et al.
Pageof 9